Yangmei Chemical Co.,Ltd (SHA:600691)
China · Delayed Price · Currency is CNY 3.170
-0.170 (-5.09%)
May 7, 2026, 3:00 PM CST
Yangmei Chemical Co.,Ltd Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 9,645 | 10,622 | 13,379 | 16,536 | 18,353 |
Other Revenue | 200.21 | 272.62 | 242.08 | 499.77 | 384.79 |
| 9,845 | 10,895 | 13,621 | 17,036 | 18,737 | |
Revenue Growth (YoY) | -9.63% | -20.01% | -20.04% | -9.08% | 4.38% |
Cost of Revenue | 9,773 | 10,580 | 13,104 | 15,806 | 16,736 |
Gross Profit | 72.13 | 314.61 | 516.76 | 1,229 | 2,001 |
Selling, General & Admin | 354.58 | 439.78 | 513.49 | 482.54 | 477.74 |
Research & Development | 147.79 | 230.39 | 245.57 | 218.62 | 227.05 |
Other Operating Expenses | 47.65 | 38.75 | 89.77 | 144.67 | 143.17 |
Operating Expenses | 448.93 | 785.95 | 981.88 | 892.64 | 794.36 |
Operating Income | -376.8 | -471.34 | -465.12 | 336.74 | 1,207 |
Interest Expense | -239.76 | -337.39 | -413.41 | -464.9 | -589.09 |
Interest & Investment Income | 57.53 | 88.11 | 130.21 | 110.84 | 88.19 |
Currency Exchange Gain (Loss) | -0 | 0 | 0.2 | -0 | 0.02 |
Other Non Operating Income (Expenses) | -11.3 | -49.18 | -399.36 | -35.18 | -41.12 |
EBT Excluding Unusual Items | -570.32 | -769.81 | -1,147 | -52.5 | 664.83 |
Gain (Loss) on Sale of Investments | - | - | - | -22.22 | -14.33 |
Gain (Loss) on Sale of Assets | 0.77 | 0.51 | - | 6.39 | 0.17 |
Asset Writedown | -345.79 | -67.97 | -727.2 | - | -28.18 |
Legal Settlements | - | -1.07 | - | - | - |
Other Unusual Items | 32.17 | 45.53 | -392.67 | 94.85 | 34.03 |
Pretax Income | -883.18 | -792.83 | -2,267 | 26.52 | 656.51 |
Income Tax Expense | 55.2 | -32.89 | 9.22 | 12.73 | 147.79 |
Earnings From Continuing Operations | -938.38 | -759.93 | -2,277 | 13.79 | 508.72 |
Minority Interest in Earnings | 113.08 | 79.21 | 911.01 | 56.28 | -77 |
Net Income | -825.3 | -680.72 | -1,366 | 70.07 | 431.71 |
Net Income to Common | -825.3 | -680.72 | -1,366 | 70.07 | 431.71 |
Net Income Growth | - | - | - | -83.77% | 234.82% |
Shares Outstanding (Basic) | 2,376 | 2,376 | 2,376 | 2,383 | 2,376 |
Shares Outstanding (Diluted) | 2,376 | 2,376 | 2,376 | 2,383 | 2,376 |
Shares Change (YoY) | -0.01% | -0.01% | -0.30% | 0.31% | 0.06% |
EPS (Basic) | -0.35 | -0.29 | -0.57 | 0.03 | 0.18 |
EPS (Diluted) | -0.35 | -0.29 | -0.57 | 0.03 | 0.18 |
EPS Growth | - | - | - | -83.82% | 234.62% |
Free Cash Flow | -115.59 | -495.75 | 1,072 | 1,429 | 603.75 |
Free Cash Flow Per Share | -0.05 | -0.21 | 0.45 | 0.60 | 0.25 |
Gross Margin | 0.73% | 2.89% | 3.79% | 7.22% | 10.68% |
Operating Margin | -3.83% | -4.33% | -3.42% | 1.98% | 6.44% |
Profit Margin | -8.38% | -6.25% | -10.03% | 0.41% | 2.30% |
Free Cash Flow Margin | -1.17% | -4.55% | 7.87% | 8.39% | 3.22% |
EBITDA | 326.35 | 336.13 | 482.41 | 1,233 | 2,098 |
EBITDA Margin | 3.31% | 3.08% | 3.54% | 7.24% | 11.20% |
D&A For EBITDA | 703.15 | 807.48 | 947.53 | 896.51 | 891.34 |
EBIT | -376.8 | -471.34 | -465.12 | 336.74 | 1,207 |
EBIT Margin | -3.83% | -4.33% | -3.42% | 1.98% | 6.44% |
Effective Tax Rate | - | - | - | 48.00% | 22.51% |
Revenue as Reported | 9,845 | 10,895 | 13,621 | 17,036 | 18,737 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.